logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

China Boton (03318.HK) repurchased 454,000 shares for HKD 1.4682 million on September 28.

date
28/09/2026
Zhito Finance APP News: China Boton (03318.HK) announced that on September 28, 2026, it spent HK$1.4682 million to repurchase 454,000 shares.
Latest
2 m ago
Gaowei Electronics (01415) repurchased 500,000 shares for HK$10.8217 million on September 28.
2 m ago
Foshan Haitian Flavouring and Food (03288.HK) repurchased 100,000 shares for HK$2.703 million on September 28.
5 m ago
Wan Leader (08482.HK): Completion of Subscription of New Shares under Specific Mandate
6 m ago
Bank of England Deputy Governor Ramsden: Paying attention to energy prices.
6 m ago
Sunshine Novo (688621.SH): Phase I clinical trial of STC008 injection for cancer cachexia in advanced solid tumors achieves expected goals.
See all latestmore
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.